Sign In
Sign Up
Two Blokes
ImmunityBio (IBRX) Reports Q1 Loss, Tops Revenue Estimates
click to rate
Posted by
Two Blokes
Mon at 1:45 PM
- Filed in
Stock
- 1 view
ImmunityBio (IBRX) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to loss of $0.20 per share a year ago.
